San Diego Union Tribune, BRITTANY MEILING, JAN. 13, 2020
A biotech startup in La Jolla has raised $85 million from notable science investors to investigate its idea for treating age-related diseases: a pill that mimics the effects of exercise and fasting.
The company, called Epirium Bio, says its scientists have discovered a new human hormone, which, when influenced, can trigger the production of more mitochondria. The depletion of the body’s mitochondria — a.k.a. “engines” of cells — is at the core of many age-related human illnesses.
To start, Epirium will be tackling rare muscle disorders, such as Duchenne muscular dystrophy, Becker muscular dystrophy and Friedreich’s ataxia.
Tuesday, January 21, 2020
Subscribe to:
Posts (Atom)
